Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE.
Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE.
复制标题
与 PLEC1 和 CHRNE 纯合突变引起的大疱性表皮松解症相关的先天性肌无力综合征。
DOI:
10.1111/j.1399-0004.2010.01602.x
复制
发表时间:
2011
影响因子:
3.5
通讯作者:
Wollmann,RL
中科院分区:
文献类型:
--
作者:
Maselli,RA;Arredondo,J;Cagney,O;Mozaffar,T;Skinner,S;Yousif,S;Davis,RR;Gregg,JP;Sivak,M;Konia,TH;Thomas,K;Wollmann,RL
Maselli RA, Arredondo J, Cagney O, Mozaffar T, Skinner S, Yousif S, Davis RR, Gregg JP, Sivak M, Konia TH, Thomas K, Wollmann RL. Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations inPLEC1andCHRNE.Mutations in the plectin gene (PLEC1)cause epidermolysis bullosa simplex (EBS), which may associate with muscular dystrophy (EBS–MD) or pyloric atresia (EBS–PA). The association of EBS with congenital myasthenic syndrome (CMS) is also suspected to result fromPLEC1mutations. We report here a consanguineous patient with EBS and CMS for whom mutational analysis ofPLEC1revealed a homozygous 36 nucleotide insertion(1506_1507ins36)that results in a reduced expression ofPLEC1mRNA and plectin in the patient muscle. In addition, mutational analysis ofCHRNErevealed a homozygous1293insG, which is a well‐known low‐expressor receptor mutation. A skin biopsy revealed signs of EBS, and an anconeus muscle biopsy showed signs of a mild myopathy. Endplate studies showed fragmentation of endplates, postsynaptic simplification, and large collections of thread‐like mitochondria. Amplitudes of miniature endplate potentials were diminished, but the endplate quantal content was actually increased. The complex phenotype presented here results from mutations in two separate genes. While the skin manifestations are because of thePLEC1mutation, footprints of mutations inPLEC1andCHRNEare present at the neuromuscular junction of the patient indicating that abnormalities in both genes contribute to the CMS phenotype.